Molecular Cobalt(II) Complexes for Tau Polymerization in Alzheimer’s Disease-Reference-Cited by-同舟云学术

Molecular Cobalt(II) Complexes for Tau Polymerization in Alzheimer’s Disease

Published:2019-09-30 Issue:16 Volume:4 Page:16702-16714
ISSN:2470-1343
Container-title:ACS Omega
language:en
Short-container-title:ACS Omega

Author:

Gorantla Nalini Vijay¹²,Landge Vinod G.³,Nagaraju Pramod Gudigenahally²⁴,Priyadarshini CG Poornima²⁴,Balaraman Ekambaram³,Chinnathambi Subashchandrabose¹²^ORCID

Affiliation:

1. Neurobiology Group, Division of Biochemical Sciences, CSIR-National Chemical Laboratory, Dr. Homi Bhabha Road, 411008 Pune, India

2. Academy of Scientific and Innovative Research (AcSIR), 411008 Pune, India

3. Department of Chemistry, Indian Institute of Science Education and Research (IISER) Tirupati, 517507 Tirupati, India

4. Department of Molecular Nutrition, CSIR-CFTRI, 570020 Mysore, India

Funder

University Grants Commission

Science and Engineering Research Board

Council for Scientific and Industrial Research

Publisher

American Chemical Society (ACS)

Subject

General Chemical Engineering,General Chemistry

Link

http://pubs.acs.org/doi/pdf/10.1021/acsomega.9b00692

Reference62 articles.

1. Function and toxicity of amyloid beta and recent therapeutic interventions targeting amyloid beta in Alzheimer's disease

2. Current progress, challenges and future prospects of diagnostic and therapeutic interventions in Alzheimer's disease

3. Microtubule-associated protein tau (tau) is a major antigenic component of paired helical filaments in Alzheimer disease.

4. Microtubule-associated protein function: Lessons from expression inspodoptera frugiperda cells

5. Phosphorylation of MAP2c and MAP4 by MARK kinases leads to the destabilization of microtubules in cells

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Transition Metal Complexes as Therapeutics: A New Frontier in Combatting Neurodegenerative Disorders through Protein Aggregation Modulation;Advanced Healthcare Materials;2024-09-02

2. Biophysical insight into anti-amyloidogenic nature of novel ionic Co(II)(phen)(H2O)4]+[glycinate]– chemotherapeutic drug candidate against human lysozyme aggregation.;Biophysical Chemistry;2024-05

3. Dual Modification of Tau by Pseudophosphorylation and Glycation Does Not Enhance Amorphous Aggregation;Cellular Physiology and Biochemistry;2024-04-22

4. Crosstalk between tau protein autoproteolysis and amyloid fibril formation;International Journal of Biological Macromolecules;2024-03

5. Microglial Uptake of Extracellular Tau by Actin-Mediated Phagocytosis;Methods in Molecular Biology;2024